The S100 proteins are a unique class of EF-hand Ca 2+ binding proteins distributed in a cell-specific, tissue-specific, and cell cycle-specific manner in humans and other vertebrates. These proteins are distinguished by their distinctive homodimeric structure, both intracellular and extracellular functions, and the ability to bind transition metals at the dimer interface. Here we summarize current knowledge of S100 protein binding of Zn
INTRODUCTION
S100 proteins are an important class of EF-hand calcium binding proteins distinguished by unique dimeric structures and functions both inside and outside cells (Donato, 2003; Donato et al., 2013; Nelson and Chazin, 1998; Potts et al., 1995; Zackular et al., 2015) . Their intracellular functions are primarily regulatory in nature, mediated by interactions with target proteins involved in a range of processes including proliferation, differentiation, and inflammation. S100 proteins are also released or secreted from cells, where they activate a variety of cell surface receptors in both an autocrine and a paracrine manner. Several S100 proteins serve as damage-associated molecular pattern recognition factors (DAMPS) in the adaptive and innate immune systems (Donato et al., 2013) , and are known to be recruited to sites of inflammation (Striz and Trebichavsky, 2004) . The S100A8/S100A9 heterodimer (termed calprotectin or CP) is the most-well studied of the S100 proteins in the immune response; it has been shown to function in the response to a range of microbial pathogens via a mechanism termed "nutritional immunity", inhibiting growth by sequestering nutrient transition metals Zn 2+ and Mn 2+ (Zackular et al., 2015) . The binding of transition metals by S100 proteins was first characterized over 30 years ago (Baudier et al., 1982 (Baudier et al., , 1984 . With a specific functional role for transition metal binding by S100 proteins now emerging, it is an appropriate time to review the field. In this monograph, we will focus on the wide range of affinities for these ions, the structural consequences of transition metal binding, and how transition metal binding modulates function. S100 proteins were first identified over five decades ago from bovine brain and are named on the basis of their solubility in 100% ammonium sulfate (Moore, 1965) . To date, there are 25 members in the human proteome and homologues have only been identified only in vertebrates, suggesting that they are "evolutionary newcomers" (Schaub and Heizmann, 2008) . Unlike other EF-hand proteins, they exhibit cell-type, tissue-specific, and cell cycle-dependent expression along with differential gene regulation (Schäfer and Heizmann, 1996) . S100 proteins are involved in a wide range of cellular functions including intracellular calcium buffering, modulation of enzyme activities, energy metabolism, and regulation of cell growth, cytoskeleton development and differentiation (Schaub and Heizmann, 2008) . While EF-hand proteins appear to have evolved to transduce intracellular Ca 2+ signals, S100 proteins have the unique ability to also function in the extracellular milieu. Some S100 proteins play essential roles in signaling and secretion of ligands for receptor binding (Donato et al., 2013) , modulated in certain cases by post-translational modifications and transition metal binding (Moroz et al., 2009a; van Dieck et al., 2009) . S100 proteins are also part of the innate immune response to bacterial pathogens (Zackular et al., 2015) . In the clinic S100 proteins serve as biomarkers for cardiomyopathy (S100A1), psoriasis (S100A7), chronic inflammation disorders and inflammatory bowel disease (S100A8/A9), and several cancers (S100A2/A4/A6) Schäfer and Heizmann, 1996) .
S100 PROTEIN STRUCTURE AND BIOCHEMISTRY
The fundamental organization for all EF-hand Ca 2+ binding proteins is a four-helix bundle domain containing a pair of helix-loop-helix EF-hand motifs (Figure 1 ). S100 proteins, the largest subgroup within the EF-hand superfamily, are comprised of an S100-specific N-terminal EF-hand with a 14-residue Ca 2+ binding loop, and a C-terminal EF-hand with a canonical 12-residue Ca 2+ binding loop . They are also distinguished from other EF-hand proteins (e.g. calmodulin) by obligate formation of dimers ( Figure 1 ) (Potts et al., 1996) ; all function as dimers or higher order oligomers except for calbindin D 9k (S100G), which is a shortened, ancestral member of the sub-family that lacks the ability to dimerize. Higher order oligomerization of S100 proteins is non-covalent and can be promoted by low affinity metal binding sites at the exterior surface of the dimer. Both Ca 2+ and transition metals (particularly Zn 2+ ) have been shown to stimulate oligomerization in vitro, and crystal structures have revealed a range of oligomeric states. However, the relevance of oligomerization of S100 proteins in vivo remains controversial except in situations where protein and metal concentrations are sufficiently high to match the conditions of the in vitro experiments. That stated, the high (millimolar) concentration of Ca 2+ in the extracellular space implies that those S100 proteins whose oligomerization is promoted by Ca 2+ may exist in higher order oligomeric states.
Like other EF-hand proteins, S100 proteins respond to Ca 2+ signals by undergoing conformational changes upon ion binding, although the conformational changes are more modest relative to canonical EF-hand Ca 2+ sensor proteins such as calmodulin (Nelson and Chazin, 1998; Nelson et al., 2002) . Despite large variations in amino acid sequence (between 20% and 60% identity), the Ca 2+ -induced conformational change in all S100 proteins involves a significant shift in the orientation of Helix III (Figure 2) (Maler et al., 2002) . Like other EF-hand Ca 2+ sensors, this conformational change results in exposure of a hydrophobic patch that serves as the key factor driving binding of targets. Although they have very similar structural architectures, S100 proteins interact with a diverse set of cellular targets. This variability is accomplished by the fine-tuning within the target binding site of each S100 protein (Bhattacharya et al., 2004) , in combination with their distinct cell-type, tissue-specific, and cell cycle-dependent expression. Current understanding of the cooperativity of Ca 2+ binding and the structural rearrangements induced by Ca 2+ binding have been reviewed in more detail elsewhere (Chazin, 2007; Ikura, 1996; Nelson and Chazin, 1998) . Here we will focus on the unique ability of S100 proteins to bind transition metals in binding sites distinct from their Ca 2+ binding sites (Heizmann and Cox, 1998) , and the corresponding effects on structure, function and biochemical properties.
BINDING OF ZINC
The first report of Zn 2+ binding to an S100 protein (S100B) was over thirty years ago (Baudier et al., 1984) . Since that time binding of Zn 2+ has been reported for S100A1, S100A2, S100A3, S100A5, S100A6, S100A7, S100A8/A9, S100A12, S100A16 and S100B (Table 1) . Zn 2+ binding S100 proteins can be classified into two categories: His-rich and Cys-rich. Sequence alignments, spectroscopic analysis, site-directed mutagenesis and high-resolution structures Figure 1 Structural features of S100 proteins. Ribbon diagrams of (A) an EF-hand motif, (B) an EF-hand domain, (C) the integration of two EF-hand domains into an S100 dimer, and (D) the alternate arrangement of two EF-hand domains in a prototypical EF-hand Ca 2+ signal modulator. S100A12 was selected as the representative member of the S100 proteins and panels A, B and C were created using the Ca 2+ -loaded protein (PDB entry 1E8A). Panel D was created using Ca 2+ -loaded calmodulin (PDB entry 1CLL). The compact nature of the S100 homodimer relative to calmodulin implies a fundamentally different structural mechanism for transduction of Ca 2+ signals. 
Trp fluorescence (Baudier, et al., 1986 ) S100A2
Competition with Zn chelator ) S100A3 4 nmol L 1 (Ca)
Competition with Zn chelator 
Equilibrium gel filtration (Schäfer, et al., 2000) 5 µmol L 1 (Ca)
Equilibrium gel filtration (Schäfer et al., 2000 ) S100A6 100 nmol L 1 (+Ca)
Fluorescence spectroscopy (Kordowska, et al., 1988 ) S100A7 100 µmol L 1 (Ca)
Equilibrium dialysis ( Vorum, et al., 1996) 
ITC (isothermal titration calorimetry) (Damo, et al., 2013 )
Fluorescent competition (Brophy, et al., 2012) 6 nmol L 1 (+Ca) Site1 (Mn/Zn) ITC (Damo, et al., 2013 )
EPR titrations ( Haydenet al., 2013) S100A12 2 and 100 µmol L 1 (Ca)
Fluorescence spectroscopy (Moroz, et al., 2009 ) S100A13 12 and 55 µmol L 1 (Ca) 62 and 120 µmol L 1 (+Ca)
EPR and NMR ( Rustandi et al., 1988) Average 0.46 µmol L 1 (Ca)
Equilibrium filtration (Nishikawa et al., 1997) revealed a conserved binding motif for the proteins with His-rich sites (S100A6, S100A7, S100A8/A9, S100A12, S100A15, S100B), with 4 His residues, or 3 His and 1 Asp residues, at the dimer interface ( Figure 3 ). The first Zn 2+ -bound structure was determined for S100A7 (Brodersen et al., 1999) , and several additional Zn 2+ -bound structures from the His-rich group have been reported since. Since the proteins are dimers, each protein binds two Zn 2+ at the two symmetrically disposed sites ( Figure 2 ).
The S100 proteins capable of binding Zn 2+ ions have af- Hence, the biological relevance of the binding of Zn 2+ has yet to be established for most S100 proteins. Another significant factor in correlating in vitro measurements to functional context is the energetic coupling of interactions with metal co-factors and targets. This issue is well recognized for EF-hand proteins in the case of the substantial differences in Ca 2+ affinity measured in the absence and presence of target proteins. Thus, an interplay between Zn 2+ and Ca
2+
binding to S100 proteins is expected. In fact, Zn 2+ binding has been reported to raise the Ca 2+ affinity of S100B by a factor of 10 and of S10012 by ~1500 fold (Dell'Angelica et al., 1994; Moroz et al., 2011) , to lower the Ca 2+ affinity of S100A2 , and to have no effect on S100A5 (Schäfer et al., 2000) .
The effects of Zn 2+ binding on the structure of S100 proteins are in general rather modest. The basic dimeric architecture observed for the apo and Ca 2+ -loaded states is retained and overall the structures are very similar (all C RMSDs (root-mean-square deviations)<1.0 Å) ( Figure 2A Figure 2B ). Detailed comparative analyses for structural differences between all states are possible for S100A7, for which structures have been determined in the apo, Ca 2+ -loaded, and Ca 2+ , Zn 2+ -loaded states, and for S100A12, for which structures have been determined in the apo, Ca 2+ -loaded, Zn 2+ -loaded, and Ca 2+ ,Cu 2+ -loaded states. (The great similarity of Zn 2+ and Cu 2+ sites is discussed below in "Binding of copper") As seen in the Zn 2+ -loaded structures of S100A7 and S100A12, two Zn 2+ ions are bound at the symmetrically disposed sites (Figure 4) , coordinated by three His N2 atoms (His17, His86, His90) and an aspartate side chain (Asp24) ( Figure 4B ) (Brodersen et al., 1999 
Figure 3
Alignments of S100 proteins containing transition metal binding sites. Structure based sequence alignment of S100 proteins from the His-rich (upper panel) and Cys-rich (lower panel) categories. Conserved residues in His-rich sites are highlighted with teal background, and those in Cys-rich sites in red background. Note the high degree of conservation in the His-rich proteins compared to the Cys-rich proteins. The alignments were generated using PROMALS3D (Pei et al., 2008) . Leon et al., 2009) . In all cases, the primary effect of Zn 2+ is to alter the orientation of Helix III ( Figure 2B ). Interestingly, Zn 2+ -binding results in poor electron density for residues 62-67 in S100A12, even though these are well defined in the structure of the apo state (Moroz et al., 2009a) . This led to the proposal that flexibility in this loop region may be induced by Zn 2+ , and thereby facilitate the ~1500-fold increase in the affinity of S100A12 for Ca 2+ . The binding of Zn 2+ has been extensively studied for S100B, most notably in conjunction with the p53 tumor suppressor protein (Lin et al., 2004) . S100B has high affinity for Zn directed mutagenesis indicated that Zn 2+ binding occurs in a similar manner to other S100 proteins with His-rich transition metal binding sites, namely His15/His25 from one subunit and His85/His89 from the other subunit. However, Zn 2+ binding to S100B causes a more pronounced kink in Helix IV than in S100A7 and S100A12 (Wilder et al., 2005) . Zn 2+ binding has been shown to increase the affinity for target peptides over the effect of Ca 2+ alone (Wilder et al., 2003) . Structural coupling of the Zn 2+ and target binding sites has been found, and this information has been incorporated into the design of S100B inhibitors of the interaction with targets such as p53. Co-crystal structures with pentamidine, an S100B inhibitor known to bind in the target binding site, were determined for both the Ca 2+ -and Ca 2+ , Zn 2+ -loaded states (Charpentier et al., 2008; Charpentier et al., 2009 ). These studies motivated the generation of new inhibitors engineered to disrupt the Zn 2+ -binding residues and Zn 2+ -induced conformational changes in S100B (Cavalier et al., 2014) .
The role of oligomerization in the function of S100 proteins has been vigorously debated. There is ample evidence of Ca 2+ -and Zn 2+ -induced oligomerization in vitro including a number of crystal structures with high order oligomerization states (Moroz et al., 2002 (Moroz et al., , 2009a Ostendorp et al., 2007 ) and a mass spectrometry study of Zn 2+ -induced tetramerization of CP (Vogl et al., 2006) . However, there is very little evidence of the functional significance of oligomerization from experiments in cells; this is an area that is in great need of further investigation. A role for oligomerization of S100 proteins is most likely in association with the extracellular functions of S100 proteins as activators of cell surface receptors (Malashkevich et al., 2010; Moroz et al., 2009a; Ostendorp et al., 2011 Ostendorp et al., , 2007 . The most well studied of these receptors is receptor for advanced glycation end products (RAGE), which has been shown to bind several S100 proteins at the cell surface and elicit an intracellular response via the NF-B signaling pathway. A role for Zn 2+ in the interaction of S100A7 and S100A15 with RAGE has been proposed (Murray et al., 2012; Wolf et al., 2008) . The Cys-rich Zn 2+ binding S100 proteins (S100A2, S100A3, S100A4) are much less studied than the His-rich group (Moroz et al., 2011) . One challenge is the absence of a conserved motif evident from alignment of these proteins (Figure 3) . The consensus view is that the Cys-rich sites coordinate Zn 2+ ions with either 4 Cys residues or 3 Cys and 1 His residue (Moroz et al., 2011) . A second challenge is that Cys-rich sites will be susceptible to redox reactions that disrupt disulfides and modulate Zn 2+ -binding. Obtaining high resolution X-ray data on the Cys-rich Zn 2+ -binding S100 proteins is difficult due to improper folding during in vitro bacterial overexpression. In fact, the majority of S100A2 and S100A4 structures were determined with Cys residues mutated to facilitate protein production. The protein production obstacle was overcome for S100A3 by producing the protein from insect cells, which promotes proper disulfide formation and folding (Kizawa et al., 2013a, b) . Crystallization of S100A3 produced in this manner identified two disulfide bonds not previously identified. These disulfides apparently play a critical structural role, as disruption of either disulfide significantly affected the Ca 2+ affinity (Unno et al., 2011) . Unfortunately, electron density for Zn 2+ ions was too weak to formally assign their presence in the structure. However, a single Cys-rich Zn 2+ site could be readily modeled, and Zn 2+ binding was proposed to be important for folding and formation of the critical disulfide bonds in S100A3. Since the majority of analyses in the past 15 years utilized recombinant protein expressed in E. coli, future studies using proteins produced from eukaryotic expression systems may enhance understanding of Zn 2+ binding to S100 proteins from the Cys-rich group.
BINDING OF COPPER
Due to their similar chemical properties, copper is anticipated to bind to most zinc binding sites in proteins. It was therefore natural to examine the binding of copper (Cu 2+ ) to S100 proteins when Zn 2+ binding was first noted for S100B (Nishikawa et al., 1997) . In that report, four Cu 2+ ions were identified per S100B dimer with an average dissociation constant (K d ) of 0.46 µmol L 1 . However, subsequent structure-based alignments predicted that there are only two high affinity sites and that the two others are weak non-specific sites (Nishikawa et al., 1997 Important insight into binding of Cu 2+ by S100 proteins was provided by the X-ray crystal structure of Ca 2+ , Cu 2+ -S100A12 (Moroz et al., 2003 and Ca 2+ , Zn 2+ structures are very similar even when comparing between different S100 proteins (Figure 4 ): the C RMSD between Ca 2+ , Cu 2+ -S100A12 and Ca 2+ , Zn 2+ -S100A7 is only 0.72 Å, and for Ca 2+ , Zn 2+ -S100B only 0.42 Å (Charpentier et al., 2008) . The great similarity in the structures of the Cu 2+ and Zn 2+ -loaded protein implies that Cu 2+ will bind to the Zn 2+ sites in other S100 proteins (Moroz et al., 2003 (Moroz et al., , 2009b .
The structural consequences of Cu 2+ binding to S100A13 have been investigated using solution NMR (Arnesano et al., 2005) . Comparisons between apo, Ca 2+ -loaded and Ca 2+ , Cu 2+ -loaded S100A13 revealed Cu 2+ causes an additional, minor opening of the Helix III-IV interface relative to the Ca 2+ -loaded state. The binding site has several unique characteristics compared to other S100 proteins, including the location of the site, as well as the ligand coordination and solvent accessibility to the Cu 2+ ion. NMR titrations of Ca 2+ -S100A13 with paramagnetic Cu 2+ ions were used to propose Glu4, Glu8, Glu11, and His48 as the Cu 2+ -chelating side chains. These correlated with electron paramagnetic resonance (EPR) studies that assigned the Cu 2+ coordination as pseudo-tetragonal with nitrogen and oxygen donor atoms. An unexpected aspect of their analysis was that the Cu 2+ ions are completely exposed to solvent, unlike the typical transition metal sites that are buried within the S100 proteins (Arnesano et al., 2005) . The authors suggested that exposure of the metal may help regulate the interaction of S100A13 with target proteins, but no data was provided in support of this speculation. Zn 2+ and Cu 2+ ions have been proposed to induce conformational changes in S100 proteins (e.g. (Vogl et al., 2006) ), although the crystal structures described above and shown in Figure 4 reveal these changes are very modest. Nevertheless, Cu 2+ binding has the potential to alter the structure of S100 proteins and therefore oligomerization and interactions with target proteins. Although Zn 2+ induced oligomerization of S100 proteins has been explored in vitro, the sole study of the effect of Cu 2+ reported no changes in oligomerization of the S100A8/S100A9 heterodimer (Vogl et al., 2006) . The only study of the effect of Cu 2+ on receptor binding revealed stimulation of the interaction of S100A4 with RAGE (Haase-Kohn et al., 2011) . Although the dearth of information about the effects of Cu 2+ on physical properties should be addressed, there is even greater urgency to establish if Cu 2+ binding has any physiological role in S100 protein function.
BINDING OF MANGANESE
Manganese is an important transition metal in biological systems (Sigel and Sigel, 2000) . It is a critical component in certain enzymatic processes (e.g. phosphorylation) and in the oxidative stress response. Recently, manganese regulation has been recognized for its essential role in contributing to the virulence of pathogenic organisms (reviewed in (Zackular et al., 2015) ), with an explicit role played by the S100A8/S100A9 heterodimer, calprotectin (CP). As will be summarized below, high affinity binding of Mn 2+ to S100 proteins is unique to CP.
All pathogenic organisms require essential nutrients from the host to survive and proliferate, including transition metals. A mechanism termed nutritional immunity, which involves sequestering the essential nutrients from the pathogen, is used by the host to fight infection. A role for transition metals besides Fe in nutritional immunity was first discovered when inductively coupled plasma mass spectrometry (ICP-MS) analysis showed that there are distinct differences in the transition metal content in and around tissues infected with Staphylococcus aureus (Corbin et al., 2008) . In particular, staphylococcal abscesses were found to be devoid of Zn 2+ and Mn 2+ ions. Proteomic imaging of the tissue revealed high concentrations of the S100A8 and S100A9 CP subunits surrounding the sites of infection. Subsequent work confirmed that CP, which is present in very large abundance in certain innate immune cells such as neutrophils, plays a critical role in the innate immune response to pathogens, functioning via the nutritional immunity mechanism through the high affinity binding and sequestration of Zn 2+ and Mn 2+ (Corbin et al., 2008; Zackular et al., 2015) . Subsequent studies using CP knockout mice have demonstrated that CP inhibits growth from other pathogenic organisms, including Acinetobacter baumannii, Candida albicans, Aspergillus fumigatus and Helicobacter pylori (Clark et al., 2016; Gaddy et al., 2014; Hood et al., 2012; Kehl-Fie et al., 2011 .
Based on the available information on the binding of Zn 2+ to S100 proteins, it was assumed that Mn 2+ bound to similar sites and completed its coordination shell with waters. Importantly, early studies showed that CP bound 2 equivalents of Zn 2+ ions, but only one equivalent of Mn 2+ . This was confirmed by site-directed mutagenesis studies that revealed Mn 2+ binds to the 4-His site (His17 and His27 from S100A8, His91 and His95 from S100A9) (Kehl-Fie et al., 2011) . Site directed mutagenesis experiments also showed that two His residues in the S100A9 C-terminal tail (His103, His105) are required for high affinity Mn 2+ binding Damo et al., 2013 Brophy and Nolan, 2015; Damo et al., 2013) ; the crystal structure shows that this is due to the unique combination of the 4-His transition metal binding site at the heterodimer interface ( Figure 5 ) and the His-rich C-terminal tail that is unique to S100A9.
BINDING OF OTHER TRANSITION METALS

Robust Zn
2+ binding at the dimerization interface led to studies of the ability of S100 proteins to bind other first-row transition metals besides Mn 2+ and Cu 2+ , but no significant affinities were observed (Fritz et al., 1998) . A recent study reports that CP is capable of sequestering ferrous (Fe 2+ ) iron from pathogenic growth media, in parallel to sequestration of Mn 2+ and Zn 2+ (Nakashige et al., 2015) . However, the relevance of ferrous iron to the host-pathogen interaction has not been firmly established, and existing in vivo data do not support a role for CP in the sequestration of iron as a defense strategy against infection (Corbin et al., 2008; Damo et al., 2013) . Sub-picomolar affinity for Fe 2+ was reported, with coordination via an uncommon 6-His coordination assigned based on Mössbauer spectroscopy (Nakashige et al., 2015) sequestration during infection will need to be investigated.
Figure 5
Three-dimensional structure of calprotectin highlighting the unique manganese binding site. The S100A8 subunit is colored blue, the S100A9 subunit gold, and the Mn 2+ ion purple. An additional low occupancy Mn 2+ ion is shown in gray. Images generated in pymol (DeLano, 2002) using coordinates deposited in the PDB for (Ca 2+ ) 4 , (Mn 2+ )-CP (4GGF).
CONCLUDING REMARKS
The ability of S100 proteins to bind transition metals at sites separate from their Ca 2+ binding sites highlights the complexities of their biochemical actions and the everchanging environments within and outside cells. Structural analyses have identified specific conformational changes induced by Ca 2+ and transition metals. However, information is urgently needed to understand if and how transition metals modulate S100 protein interactions with their targets. Questions regarding oligomerization state and whether transition metal binding is needed for signaling to occur also need to be addressed. Substantial evidence for S100 proteins in human disease suggests there is significant potential in pursuing S100 proteins as therapeutic targets and motivates ongoing efforts in multiple laboratories to develop S100 protein-specific inhibitors.
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